US Broker Ratings

Globus Medical, Inc. (GMED) Stock Analysis: Strong Growth Potential with a 22.9% Revenue Surge

Investors often seek companies with robust growth trajectories and innovative product offerings, and Globus Medical, Inc. (NYSE: GMED) certainly fits that profile. This healthcare giant, specializing in medical devices, is..

BioMarin Pharmaceutical Inc. (BMRN)

⚠️ No article content returned.

..

Novo Nordisk A/S (NVO) Stock Analysis: Impressive ROE and 17.75% Upside Potential

Novo Nordisk A/S (NYSE: NVO), a titan in the global healthcare sector, continues to capture investor attention with its robust performance metrics and strategic initiatives. Headquartered in Bagsvaerd, Denmark, the..

Illumina, Inc. (ILMN) Investor Outlook: Navigating a Complex Terrain with Strategic Insights

Illumina, Inc. (NASDAQ: ILMN), a leading player in the healthcare sector specializing in diagnostics and research, has garnered significant attention from investors seeking exposure to genomic solutions. Based in San..

Molina Healthcare Inc (MOH): Investor Outlook with a 20% Potential Upside and Analyst Consensus

Molina Healthcare Inc (NYSE: MOH) stands at a pivotal juncture, drawing significant attention from investors intrigued by its robust growth potential and attractive valuation metrics. As a major player in..

argenx SE (ARGX) Stock Analysis: Unveiling a 4.57% Upside Potential with Strong Buy Ratings

argenx SE (ARGX), a prominent player in the biotechnology sector, is drawing significant attention from investors, not least due to its substantial market capitalization of $57.23 billion. Specializing in the..

Viatris Inc. (VTRS) Stock Analysis: Exploring the 15.92% Potential Upside and Robust Dividend Yield

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is drawing attention from investors with its compelling value proposition. With a market capitalization of $12.08 billion, Viatris operates..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring Its 4.9% Potential Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a major player in the healthcare sector, has carved a niche in the medical distribution industry, offering an extensive range of products and services to..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling an 18% Potential Upside Amid Robust Analyst Ratings

In the dynamic landscape of the biotechnology industry, Royalty Pharma plc (NASDAQ: RPRX) stands out with its unique business model and promising growth prospects. With a market capitalization of $22.7..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring a 21.60% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare sector, has piqued investor interest with its diversified operations across hospital and ambulatory care services. With a market..

Exelixis, Inc. (EXEL) Stock Analysis: Unpacking the 5.86% Potential Upside in Biotechnology

As investors navigate the dynamic landscape of biotech stocks, Exelixis, Inc. (NASDAQ: EXEL) commands attention with its robust market cap of $11.44 billion and a promising potential upside of 5.86%...

Tempus AI, Inc. (TEM) Stock Analysis: Uncovering a 28.40% Upside in the Healthcare Tech Space

Tempus AI, Inc. (TEM) is carving a niche in the healthcare technology sector, where it operates as a premier provider of next-generation sequencing diagnostics and advanced molecular pathology testing. As..

AbbVie Inc. (ABBV) Investor Outlook: Navigating a Robust Market Cap with Potential Upside

AbbVie Inc. (NYSE: ABBV), a stalwart in the healthcare sector, commands a significant presence in the drug manufacturing industry. With a market capitalization of $417.6 billion, this biopharmaceutical giant continues..

Insmed Incorporated (INSM) Stock Analysis: Navigating Biotech Potential with a 7.73% Upside

Insmed Incorporated (NASDAQ: INSM), a notable player in the biotechnology sector, is capturing the attention of investors with its strategic focus on developing therapies for serious and rare diseases. Headquartered..

Encompass Health Corporation (EHC): Investor Outlook on a Robust 22.72% Potential Upside

Encompass Health Corporation (EHC), a leading player in the healthcare sector, continues to capture investor attention with its impressive growth metrics and robust analyst ratings. With a current market capitalization..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: 23% Upside Potential Amid Strong Buy Ratings

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, specializes in developing pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders. With a market capitalization of $14.14 billion, this San..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Unpacking a 13% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands out in the biotechnology sector with its impressive market cap of $109.42 billion and a robust portfolio targeting cystic fibrosis (CF) therapies. As a..

Danaher Corporation (DHR) Stock Analysis: Exploring an 11.79% Potential Upside Amidst Robust Buy Ratings

Danaher Corporation (NYSE: DHR) continues to capture the attention of investors in the healthcare sector, particularly within the diagnostics and research industry. With a substantial market capitalization of $162.82 billion,..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Strong Growth Trajectory and Analyst Confidence

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is making waves in the biotechnology sector with its innovative approach to therapeutics based on ribonucleic acid interference (RNAi). As the company continues to expand..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Balancing Potential Upside of 96% with Current Challenges

Investors in the biotechnology sector are no strangers to volatility, but the current landscape for Summit Therapeutics Inc. (NASDAQ: SMMT) presents a unique mix of opportunity and caution. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds